Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function

Susan M. Richards, William J Murphy

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The conclusion that prolactin plays a role in immune and hematopoietic function was initially based upon observations in hormone deficient animals. The multiple cell function defects associated with hypophysectomy or bromocriptine treatment were reversed by administration of prolactin. Since these initial observations, an increasing body of literature supports prolactin having a role in the immune and hematopoietic system. A recombinant form of human prolactin (r-hPRL) has been produced and evaluated in a wide variety of preclinical models. Both in vitro and in vivo studies suggest that r-hPRL can enhance cell function, accelerate lymphoid and myeloid reconstitution and promote hematopoiesis. The multi-lineage effect of r-hPRL makes it an attractive candidate for clinical situations presenting with immune deficiency or myelosuppression. (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)56-62
Number of pages7
JournalJournal of Neuroimmunology
Volume109
Issue number1
DOIs
StatePublished - Sep 1 2000
Externally publishedYes

Fingerprint

Prolactin
Proteins
Therapeutics
Hematopoietic System
Hypophysectomy
Bromocriptine
Hematopoiesis
Immune System
Hormones

Keywords

  • Cell function defects
  • Hematopoietic function
  • Immune function
  • Prolactin
  • Therapeutic protein

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function. / Richards, Susan M.; Murphy, William J.

In: Journal of Neuroimmunology, Vol. 109, No. 1, 01.09.2000, p. 56-62.

Research output: Contribution to journalArticle

@article{11fd5ff7c52e42c2912975fa03a384d1,
title = "Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function",
abstract = "The conclusion that prolactin plays a role in immune and hematopoietic function was initially based upon observations in hormone deficient animals. The multiple cell function defects associated with hypophysectomy or bromocriptine treatment were reversed by administration of prolactin. Since these initial observations, an increasing body of literature supports prolactin having a role in the immune and hematopoietic system. A recombinant form of human prolactin (r-hPRL) has been produced and evaluated in a wide variety of preclinical models. Both in vitro and in vivo studies suggest that r-hPRL can enhance cell function, accelerate lymphoid and myeloid reconstitution and promote hematopoiesis. The multi-lineage effect of r-hPRL makes it an attractive candidate for clinical situations presenting with immune deficiency or myelosuppression. (C) 2000 Elsevier Science B.V.",
keywords = "Cell function defects, Hematopoietic function, Immune function, Prolactin, Therapeutic protein",
author = "Richards, {Susan M.} and Murphy, {William J}",
year = "2000",
month = "9",
day = "1",
doi = "10.1016/S0165-5728(00)00303-9",
language = "English (US)",
volume = "109",
pages = "56--62",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function

AU - Richards, Susan M.

AU - Murphy, William J

PY - 2000/9/1

Y1 - 2000/9/1

N2 - The conclusion that prolactin plays a role in immune and hematopoietic function was initially based upon observations in hormone deficient animals. The multiple cell function defects associated with hypophysectomy or bromocriptine treatment were reversed by administration of prolactin. Since these initial observations, an increasing body of literature supports prolactin having a role in the immune and hematopoietic system. A recombinant form of human prolactin (r-hPRL) has been produced and evaluated in a wide variety of preclinical models. Both in vitro and in vivo studies suggest that r-hPRL can enhance cell function, accelerate lymphoid and myeloid reconstitution and promote hematopoiesis. The multi-lineage effect of r-hPRL makes it an attractive candidate for clinical situations presenting with immune deficiency or myelosuppression. (C) 2000 Elsevier Science B.V.

AB - The conclusion that prolactin plays a role in immune and hematopoietic function was initially based upon observations in hormone deficient animals. The multiple cell function defects associated with hypophysectomy or bromocriptine treatment were reversed by administration of prolactin. Since these initial observations, an increasing body of literature supports prolactin having a role in the immune and hematopoietic system. A recombinant form of human prolactin (r-hPRL) has been produced and evaluated in a wide variety of preclinical models. Both in vitro and in vivo studies suggest that r-hPRL can enhance cell function, accelerate lymphoid and myeloid reconstitution and promote hematopoiesis. The multi-lineage effect of r-hPRL makes it an attractive candidate for clinical situations presenting with immune deficiency or myelosuppression. (C) 2000 Elsevier Science B.V.

KW - Cell function defects

KW - Hematopoietic function

KW - Immune function

KW - Prolactin

KW - Therapeutic protein

UR - http://www.scopus.com/inward/record.url?scp=0034284090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034284090&partnerID=8YFLogxK

U2 - 10.1016/S0165-5728(00)00303-9

DO - 10.1016/S0165-5728(00)00303-9

M3 - Article

C2 - 10969182

AN - SCOPUS:0034284090

VL - 109

SP - 56

EP - 62

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1

ER -